Wolff Henry Ward Insider Trades

Insider Trading History

Track insider trading activity for Wolff Henry Ward. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $6 20,000 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.3k 20,000 shares
$3.91
$0.00
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $6 20,000 shares
Last Trade
Jun 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$912k 20,000 shares
$45.60
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Director
Holding Value $0 0 shares
Last Trade
Jul 02, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$0.00
Viracta Therapeutics
Viracta Therapeutics VIRX
Director
Holding Value $588 60,000 shares
Last Trade
Jun 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $6 20,000 shares
Last Trade
Jun 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.1M 20,000 shares
$105.00
$0.00
Viracta Therapeutics
Viracta Therapeutics VIRX
Director
Holding Value $588 60,000 shares
Last Trade
Jun 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Director
Holding Value $0 0 shares
Last Trade
Jun 03, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $3.3 11,000 shares
Last Trade
May 30, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 11,000 shares
$108.40
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Director
Holding Value $0 0 shares
Last Trade
Mar 12, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Director
Holding Value $0 15,766 shares
Last Trade
Mar 12, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Viracta Therapeutics
Viracta Therapeutics VIRX
Director
Holding Value $61.3 6,250 shares
Last Trade
Jun 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $3.3 11,000 shares
Last Trade
May 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.13M 11,000 shares
$103.00
$0.00
Viracta Therapeutics
Viracta Therapeutics VIRX
Director
Holding Value $368 37,500 shares
Last Trade
Feb 28, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Director
Holding Value $0 0 shares
Last Trade
Oct 05, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Portola Pharmaceuticals
Portola Pharmaceuticals PTLA
Director
Holding Value $0 12,000 shares
Last Trade
Oct 05, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $3.3 11,000 shares
Last Trade
Jun 09, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.12M 11,000 shares
$284.00
$0.00
Calithera Biosciences
Calithera Biosciences CALA
Director
Holding Value $3.3 11,000 shares
Last Trade
Jun 14, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 11,000 shares
$95.20
$0.00
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Exec VP & CFO
Holding Value $45.2k 215,703 shares
Last Trade
Dec 12, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$52.8k 6,087 shares
$8.68
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Exec VP & CFO
Holding Value $43.3k 206,829 shares
Last Trade
Dec 12, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$120k 13,778 shares
$8.68
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Exec VP & CFO
Holding Value $46.5k 221,790 shares
Last Trade
Dec 11, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$56.6k 6,522 shares
$8.68
$0.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up